Education
About Us
Working with TipRanks
Follow Us
Cormedix (CRMD)
NASDAQ:CRMD
Total Valuation
Cormedix has a market cap or net worth of $505.92M. The enterprise value is $509.01M.
Market Cap$505.92M
Enterprise Value$509.01M
Share Statistics
Cormedix has 79,050,390 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding79,050,390
Owned by Insiders2.90%
Owned by Institutions4.51%
Financial Efficiency
Cormedix’s return on equity (ROE) is 0.40 and return on invested capital (ROIC) is 24.90%.
Return on Equity (ROE)0.40
Return on Assets (ROA)0.20
Return on Invested Capital (ROIC)24.90%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee4.87M
Profits Per Employee2.55M
Employee Count64
Asset Turnover0.38
Inventory Turnover1.21
Valuation Ratios
The current PE Ratio of Cormedix is 5.1. Cormedix’s PEG ratio is -0.00604.
PE Ratio5.1
PS Ratio2.69
PB Ratio2.07
Price to Fair Value2.07
Price to FCF4.85
Price to Operating Cash Flow2.88
PEG Ratio-0.00604
Income Statement
In the last 12 months, Cormedix had revenue of 311.71M and earned 163.06M in profits. Earnings per share was 2.25.
Revenue311.71M
Gross Profit275.75M
Operating Income150.14M
Pretax Income150.02M
Net Income163.06M
EBITDA165.13M
Earnings Per Share (EPS)2.25
Cash Flow
In the last 12 months, operating cash flow was 175.05M and capital expenditures -584.20K, giving a free cash flow of 174.46M billion.
Operating Cash Flow175.05M
Free Cash Flow174.46M
Free Cash Flow per Share2.21
Dividends & Yields
Cormedix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.53
52-Week Price Change-38.34%
50-Day Moving Average7.81
200-Day Moving Average10.89
Relative Strength Index (RSI)35.40
Average Volume (3m)1.78M
Important Dates
Cormedix upcoming earnings date is May 7, 2026, TBA (Confirmed).
Last Earnings DateMar 5, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Cormedix as a current ratio of 2.01, with Debt / Equity ratio of 36.74%
Current Ratio2.01
Quick Ratio1.84
Debt to Market Cap0.17
Net Debt to EBITDA0.02
Interest Coverage Ratio53.97
Taxes
In the past 12 months, Cormedix has paid -13.04M in taxes.
Income Tax-13.04M
Effective Tax Rate-0.09
Enterprise Valuation
Cormedix EV to EBITDA ratio is 5.09, with an EV/FCF ratio of 4.87.
EV to Sales2.70
EV to EBITDA5.09
EV to Free Cash Flow4.87
EV to Operating Cash Flow4.80
Balance Sheet
Cormedix has $149.52M in cash and marketable securities with $148.91M in debt, giving a net cash position of $605.00K billion.
Cash & Marketable Securities$149.52M
Total Debt$148.91M
Net Cash$605.00K
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.05
Margins
Gross margin is 88.46%, with operating margin of 48.17%, and net profit margin of 52.31%.
Gross Margin88.46%
Operating Margin48.17%
Pretax Margin48.13%
Net Profit Margin52.31%
EBITDA Margin52.98%
EBIT Margin48.17%
Analyst Forecast
The average price target for Cormedix is $13.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$13.25
Price Target Upside107.03% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast1647.67%
EPS Growth Forecast―